EQT targets surgical technology with Corza Biosurgery deal
Global investment firm EQT is to acquire the biosurgery business unit from Chicago-based private equity firm GTCR’s portfolio company, Corza Medical. Financial details of the transaction remain undisclosed. The deal, through the EQT X fund, is expected to close in Q4 2026, subject to regulatory clearances and customary closing conditions. The divestiture represents a significant corporate carve-out for Corza Medical. Under…
EQT and co-investors fully exit Galderma
Swedish private equity firm EQT has fully divested from Swiss-based global pure-play dermatology company Galderma. On March 13, EQT and its co-investors, including the Abu Dhabi Investment Authority and Singapore’s GIC, offloaded their remaining 14.3% stake. The sale of approximately 34 million shares generated roughly 4.9 billion Swiss francs (£4.65bn), making it the largest sponsor-backed block trade in history. The…